IPS.PA
T2Ipsos S.A.
Alt & Market Data '24: Consumer DataPolitical Spend '26: Ad Agencies & Polling
OverviewIpsos S.A. is a global market research firm providing survey-based insights and data analysis to companies and institutions. It offers specialized solutions acr
Ipsos S.A. is a global market research firm providing survey-based insights and data analysis to companies and institutions. It offers specialized solutions across consumer (half of business), public affairs, healthcare, and client/employee segments. Leveraging advanced AI and digital platforms like Ipsos.Digital, the company returned to organic growth across all regions and audiences in Q2 2026, driven by strong Public Affairs and China performance.
- What They Do (Plain English & Analogies)
- Ipsos is like a global detective agency for businesses and governments. Instead of solving crimes, they solve mysteries about people's opinions, behaviors, and preferences. They do this by asking questions through surveys, observing how people interact with products or services, and analyzing data from sources like social media. They then turn all this information into clear insights that help their clients make better decisions, whether it's launching a new product, understanding public sentiment, or improving customer experience. Think of them as providing the 'why' behind what people do, helping companies and public bodies navigate a complex world. They are increasingly using artificial intelligence to speed up this process and provide insights faster, often within 48 hours.
- Very Brief History
- Founded in 1975 in Paris, France, Ipsos S.A. has grown into one of the world's leading market research and opinion polling companies. Over the decades, it has expanded its global footprint and diversified its service offerings, notably through strategic acquisitions like The BVA Family in 2025, and by embracing new technologies such as artificial intelligence and digital platforms to enhance its research capabilities.
- "Street Stereotype"
- Ipsos is generally perceived by investors and analysts as a leading global market research and polling firm, a bellwether for consumer and public sentiment. It's often seen as a beneficiary of major election cycles due to its Public Affairs business, and increasingly, as a company investing in and leveraging advanced data analytics and AI to stay competitive in a rapidly evolving insights industry.
- Subsidiaries On Linked In*
- Ipsos Bva — Operating name for Ipsos France after BVA Family acquisition; LinkedIn: Ipsos Bva
- Ipsos Doxa — Operating name for Ipsos Italy after BVA Family acquisition; LinkedIn: Ipsos Doxa
- BDRC — Now operating under the Ipsos brand in the UK after BVA Family acquisition; LinkedIn: BDRC
- PRS IN VIVO — Specializes in pack testing, part of BVA Family acquisition; LinkedIn: PRS IN VIVO
- Seventh Decimal — Acquired in January 2026 for Audience Measurement expertise; LinkedIn: Seventh Decimal
- Customer Sectors & Example Clients
- Ipsos serves a diverse range of customer sectors including Public Affairs (e.g., government contracts in the U.S., France, U.K., European Commission), Consumer and Packaged Goods (CPG) clients (e.g., major beverage and home care companies), Healthcare/Pharma Industry (focused on oncology and GLP-1 treatments), Technology, Automotive (especially in China), and Clients & Employees (e.g., for audience measurement and employee engagement). Specific top clients include their 'top 30 clients' where they have dedicated account leadership, and large international and local clients in China's technology and automotive sectors.
- New Customers / Segments They'Re Targeting
- Ipsos is targeting increased demand from CPG clients and pharmaceutical companies, particularly in areas like oncology and GLP-1 obesity treatments. They are also expanding their reach by rolling out globally managed services worldwide and enriching the functionalities of their digital services, supported by AI solutions, to attract a broader range of clients seeking faster and more detailed insights. The company is also focusing on specific initiatives for China and the U.S., capitalizing on the technological advancements in these markets.
- Supply Chain And Sourcing Geographies
- Ipsos's 'supply chain' primarily involves the sourcing of data and insights from people. They increasingly rely on their own 'proprietary panels' and are focusing on 'in-sourcing' respondents rather than outsourcing to third-party providers, which is a key part of their operational transformation. Data collection methods include face-to-face interviews (conducted in many large markets and countries), online and mobile research (device-agnostic surveys), social media monitoring, and behavioral measurement using videos. This data is sourced globally across their operating markets, which span Europe, the Middle East, Africa, the Americas, and Asia-Pacific.
- Sales Geographies And Expansion Plans
- Ipsos currently sells its services globally, with operations across Europe, the Middle East, Africa, the Americas, and Asia-Pacific. EMEA generated €587.6 million in revenue in H1 2026, the Americas €396.6 million, and Asia Pacific €185.9 million. North America, France, the U.K., and China are currently driving their growth. The acquisition of The BVA Family significantly strengthened their presence in France, the U.K., and Italy. They disposed of a majority stake in their Russian business in 2025. Management indicates plans to expand sales and accelerate growth, particularly in China, where they have strong momentum with technology and automotive clients, and in the U.S., with specific initiatives targeting the tech industry. They are also implementing Globally Managed Services (GMS) powered by Ipsos.Digital across key markets to drive consistent service delivery and growth.
- How Key Themes May Help/Hurt
- The 'Political Spend '26: Ad Agencies & Polling' theme is a significant tailwind for Ipsos. The company's Public Affairs business, a key component of this theme, is experiencing rising demand and increased order intake, securing prominent multiyear government contracts in critical markets like the U.S., France, and the U.K.. This segment's countercyclical nature provides resilience, especially during periods of political instability. The increasing adoption of AI and digital transformation in political campaigning, as highlighted by the theme, also benefits Ipsos as it aggressively leverages AI and platforms like Ipsos.Digital to enhance targeting, efficiency, and creative output for clients. However, increased regulatory scrutiny and demands for greater transparency in political advertising, particularly concerning digital platforms and AI-generated content, could impose compliance costs and restrict certain ad practices, creating legal uncertainty and operational challenges for Ipsos and its clients.
3 Main Long-Term Bull Details
- "Horizons" Strategic Plan & AI Integration: Ipsos's comprehensive "Horizons" strategy, which includes leveraging multi-specialist offerings, globally managed services, and substantial investment in AI, is poised to drive accelerated growth and enhance client value through innovative solutions like Ipsos Synthesio, Ipsos.Digital, and new AI-powered products like Product Studio. This transformation aims to reduce survey lead times to under 48 hours, significantly improving efficiency and client responsiveness.
- Strong Global Footprint & Multi-Specialist Approach: With operations in 66 markets and a commitment to its multi-specialist model, Ipsos benefits from a diversified revenue base across Consumer, Public Affairs (which is rebounding strongly), Clients & Employees, and Healthcare segments, providing a robust competitive advantage in serving diverse global client needs.
- Rebounding Public Affairs Business & Countercyclical Nature: The Public Affairs business is experiencing a significant rebound, with strong organic growth and contract wins, demonstrating its countercyclical nature and renewed interest from public and private decision-makers. This segment's ability to secure large-scale, complex surveys, even amidst political instability, provides a resilient and growing revenue stream.
3 Main Long-Term Bear Details
- Geopolitical Volatility & Macroeconomic Headwinds: Ongoing geopolitical tensions, particularly the protracted conflict in the Middle East, have led to a 'wait-and-see' attitude from some customers, causing program postponements and a downward revision of global growth outlooks. This macroeconomic volatility, coupled with adverse foreign exchange effects, could impact global client spending and reported growth.
- Integration Challenges and Profitability Pressures: While the integration of the BVA Family acquisition is proceeding according to plan, it initially had a dilutive effect on gross margin. Ongoing investments in AI and technology, along with the disposal of profitable Russian operations, necessitate disciplined cost management to maintain overall profitability targets.
- Rapidly Evolving Digital & AI Landscape: The fast-paced evolution of digital advertising and AI technologies, including concerns about AI-generated content and data privacy, presents ongoing regulatory and operational challenges. Ipsos must continuously adapt its AI strategies and ensure compliance, which could incur costs and restrict certain practices, impacting the effectiveness of digital campaigns.
- Competitors And Differentiation
- Ipsos's competitors include other global market research firms. According to PitchBook, some competitors are Ronin International, PSB Insights, Netquest, Roy Morgan Research, and The Kantar Group. Ipsos differentiates itself through its global footprint across 66 markets, its multi-specialist approach with 16 business lines and 70 types of offers, and its unique ability to conduct large-scale, complex surveys, including face-to-face and telephone interviews. A key differentiator is its strategic investment in artificial intelligence and digital platforms like Ipsos.Digital, which enables faster, more detailed, and cost-effective services, often aiming to complete surveys in under 48 hours. The company also emphasizes its proprietary panels and the in-sourcing of respondents as a critical competitive advantage.
- Recent Performance & What The Market'S Focused On
- Ipsos demonstrated a significant rebound in performance in Q2 2026, with organic growth accelerating to 3.0% compared to a decline of 1.4% in Q1 2026. For the first half of 2026, total revenue reached €1.17 billion, up 1.3% year-over-year, with organic growth turning positive at 0.8%. The order book also strengthened, growing 1.6% in Q2 and 1.2% for the half, covering about 75% of annual revenue. All regions and audience segments returned to positive organic growth in Q2. The market is focused on this clear acceleration in organic growth, the successful execution of the 'Horizons' strategic program, particularly the ramp-up of AI-powered solutions and globally managed services, and the company's ability to achieve its full-year organic growth guidance of above 2%. Investors also welcomed the confirmed €100 million share buyback program.
- Revenue Segments And Estimated Mix
- Consumers — Mix: ~48.4%; Source: H1 2026 results; Trend: 1.1% organic growth for H1 2026, consistent performance across both quarters
- Clients & Employees — Mix: ~20.5%; Source: H1 2026 results; Trend: 0.4% organic contraction for H1 2026, returned to growth in Q2 with 2.4% expansion
- Citizens (Public Affairs and Corporate Reputation) — Mix: ~17.2%; Source: H1 2026 results; Trend: 2.8% organic growth for H1 2026, with Q2 acceleration to 7.8%
- Doctors & Patients — Mix: ~13.9%; Source: H1 2026 results; Trend: 0.5% organic decline for H1 2026, but turned positive in Q2 with 3.3% growth
- Product Brands
- Ipsos Synthesio
- Ipsos.Digital
- Ipsos Bva
- Ipsos Doxa
- PRS IN VIVO
- Product Studio
Bull / Bear DetailsIpsos S.A. (IPS.PA) presents a compelling bullish case as of 2026-07-24, driven by its strong return to organic growth across all regions and audiences in Q2 20
Thesis
Ipsos S.A. (IPS.PA) presents a compelling bullish case as of 2026-07-24, driven by its strong return to organic growth across all regions and audiences in Q2 2026. Strategic execution of the 'Horizons' plan, accelerating AI and digital platform adoption, and a robust Public Affairs business benefiting from the "Political Spend '26" theme are expected to drive sustained revenue expansion and core profitability improvements, supported by a strong balance sheet.
Bull case
The rebound of Ipsos's Public Affairs business is a significant tailwind, showing countercyclical strength with rising demand and orders. It achieved strong organic growth of nearly 8% in Q2, securing multiyear government contracts in key markets like the U.S. and U.K., directly benefiting from the "Political Spend '26" theme and renewed interest from decision-makers.
Ipsos is aggressively leveraging AI and digital transformation through its 'Horizons' program, driving market leadership. The Ipsos.Digital platform continues double-digit growth, and new AI-powered products like Product Studio and AI moderation are enhancing efficiency, reducing survey lead times to under 48 hours, and creating value for clients globally.
Ipsos demonstrated a strong return to organic growth of 3% in Q2 2026, leading to 0.8% for H1, with all regions and audiences contributing positively. This broad-based recovery, coupled with robust performance in China and the pharmaceutical sector, is underpinned by a strong balance sheet, low leverage, and a commitment to shareholder returns via dividends and share buybacks.
Bear case
Despite revenue growth, Ipsos's gross margin dropped 70 basis points in H1, and operating margin declined 40 basis points, partly due to the dilutive effect of the BVA Family acquisition. Additionally, the business mix shifted towards lower-gross-margin Public Affairs projects, and non-recurring costs from halted IT projects further impacted profitability.
Broader macroeconomic volatility and geopolitical risks, particularly the protracted Middle East conflict, continue to pose headwinds. This has led to a "wait-and-see" attitude from some clients, program postponements, and a downward revision of the IMF's growth outlook, creating uncertainty for global client spending beyond current expectations.
Ipsos operates in highly competitive markets, leading to ongoing pressure on prices. While the company aims to offset lower unit prices with higher volumes through digital platforms like Ipsos.Digital, this dynamic could challenge margin expansion, especially if volume growth does not fully compensate for pricing concessions in certain segments.
Bull / Bear Case
- Bear Case
- The bear case for Ipsos S.A. is anchored by its negative organic growth of -1.4% in Q1 2026, coupled with a significant negative currency impact of 5.4%. Geopolitical volatility, particularly the ongoing Middle East conflict, has already led to a 4.4% organic decline in that region and poses a risk of broader macroeconomic impact, potentially causing client cancellations or delays. The integration of acquisitions like the BVA Family and the disposal of the profitable Russian business are expected to be a drag on profitability in 2026, requiring disciplined cost management to maintain margins. Furthermore, the gradual nature of the 'Horizons' strategy execution means that a sustained recovery in organic growth may take longer to materialize, leaving the company exposed to a volatile market environment.
- Bull Case
- Ipsos S.A. presents a compelling bull case driven by the rebound of its Public Affairs business, which is now securing significant multiyear government contracts in key markets like the U.S., France, and the U.K.. The company's 'Horizons' strategic plan, with its focus on leveraging multi-specialist offerings and accelerating AI and digital platform adoption, is expected to drive gradual revenue expansion throughout 2026. Ipsos.Digital platform recorded double-digit growth in Q1 2026, and new AI-powered products are slated for launch, enhancing client value. Robust performance in China, fueled by AI-driven offers, and strong sales momentum with its top 30 clients further support the outlook for sustained activity and core profitability improvements.
- More Compelling & Why
- Bull. Ipsos trades at a P/E ratio of approximately 6-8x, significantly below the European Media industry average of 15.4x and the French market average of over 16x. Its Free Cash Flow (FCF) Yield of 15.17% is also substantially higher than the industry median of 3.56%. This deep undervaluation, combined with management's confidence in a full-year organic growth acceleration (2-3%) driven by the Public Affairs rebound and AI integration, makes the bull case more compelling. My view would flip if Ipsos fails to demonstrate a clear acceleration in organic revenue growth in Q2 2026 and subsequent quarters, or if the geopolitical situation escalates to significantly impact global client spending beyond current expectations.
Key Factors
| Key Factor | Why It Matters | What To Watch | What It Signals | Where/How To Track | Free Alt Data | Paid Alt Data |
|---|---|---|---|---|---|---|
| H2 Operating Margin Trajectory and Cost Control | Profitability is crucial for investor confidence. Achieving the full-year operating margin target (similar to 2025) implies effective cost control and successful integration of acquisitions, validating management's ability to deliver on financial guidance despite H1 dilution. | Operating margin for H2 2026. Commentary on continued cost optimization efforts, impact of BVA Family integration, and the overall business mix on gross and operating margins. | H2 operating margin showing significant improvement over H1 (7.9%) to bring the full-year margin in line with 2025 levels = bullish. | Company's Q3 2026 earnings release on October 23, 2026, and full-year 2026 earnings release (expected early 2027). | Company investor presentations for updates on cost structure and efficiency initiatives. | S&P Capital IQ: Ipsos S.A. (IPS.PA) historical and consensus margin data. |
| Asia Pacific (China-driven) Organic Growth | China is highlighted as a key growth engine and a market where Ipsos is gaining market share, validating its strategic focus and innovative AI-driven offerings in a crucial and rapidly evolving region. | Organic growth rate for the Asia Pacific region in Q3 2026 (H1 2026 was 2%). Specific commentary on China's continued strong momentum, especially in technology and automotive sectors, and market share gains. | Asia Pacific organic growth remaining positive and accelerating beyond 2% in Q3, with specific mention of China's strong contribution and market share gains = bullish. | Company's Q3 2026 earnings release and conference call on October 23, 2026. | China National Bureau of Statistics: Retail sales data for automotive and electronics. Industry reports on China's market research sector. | Sensor Tower / Apptopia: App download trends for Ipsos apps in China (if applicable). Macroeconomic data providers for China's tech and automotive sectors. |
| Organic Order Book Growth and Conversion to Revenue | Order book growth is a leading indicator for future revenue, directly validating the effectiveness of Ipsos's commercial efforts and the "Horizons" strategy, particularly for the H2 2026 outlook. It signals the company's ability to translate commercial momentum into top-line growth. | Organic order book growth percentage for Q2 2026 (reported as 1.2% at end of June). The percentage of expected full-year 2026 revenue represented by the order book at the end of Q2 2026 (reported as 75%). | Organic order book growth exceeding 1.2% or the order book representing >75% of expected full-year revenue at Q2-end = bullish. Continued acceleration in order intake in Q3 = bullish. | Company's Q3 2026 earnings release and conference call on October 23, 2026. | Company investor relations website for press releases and financial reports. | Bloomberg Terminal: IPS.PA Order Book Data (if available), FactSet: Consensus Revenue Estimates (to compare against order book conversion). |
| Ipsos.Digital Platform Organic Growth and AI Product Rollout | This factor is central to Ipsos's "Horizons" strategic plan, driving efficiency, innovation, and competitive differentiation through technology and AI, which are crucial for long-term growth and market leadership. | Ipsos.Digital organic growth rate (reported as double-digit in Q2). Announcements of new functionalities for Ipsos.Digital in H2 2026. Specific updates on the adoption and client feedback for Product Studio (launched Q2) and other AI tools. | Ipsos.Digital maintaining double-digit growth and positive client adoption of new AI products = bullish. | Company's Q3 2026 earnings release and conference call on October 23, 2026. Company press releases and investor presentations. | Ipsos corporate website: Product news and updates. Industry tech news for AI in market research. | SimilarWeb: Ipsos.Digital web traffic trends. Thinknum: Ipsos job postings for AI/digital roles (indicating investment). |
| Citizens Segment (Public Affairs) Organic Growth | The Citizens segment, particularly Public Affairs, is a key driver of the "Political Spend '26" thesis and has shown a significant turnaround, confirming its countercyclical nature and strong contribution to overall organic growth. | Organic growth rate of the Citizens segment in Q2 2026 (reported as close to 8%). Commentary on new significant multiyear government contracts in the U.S., France, or U.K. in Q3. | Citizens segment organic growth maintaining or exceeding 8% in Q3 = bullish. Announcement of new large government contracts = bullish. | Company's Q3 2026 earnings release and conference call on October 23, 2026. | Government contract award databases (e.g., USASpending.gov for US contracts, Tenders Electronic Daily for EU) for large public sector contracts. | GovWin IQ: Government contract awards and pipeline analysis. |
Key Reported Metrics, Reratings Triggers & ResultsThe Citizens segment, which includes Public Affairs, is highlighted as a key driver of growth and a turnaround story, with rising demand and significant governm
| Key reported metrics | Rerating thresholds | Earnings results | ||||||
|---|---|---|---|---|---|---|---|---|
| Metric | Last period | Why it matters | What's needed for rerating | Rerating context | Earnings date | Actual reported | Hit target? | Notes |
| Citizens Segment Organic Growth | -2.3% | The Citizens segment, which includes Public Affairs, is highlighted as a key driver of growth and a turnaround story, with rising demand and significant government contract wins. Its performance is crucial for validating the multi-specialist strategy and contributing to overall organic growth in 2026. | The Citizens Segment Organic Growth needs to turn positive, ideally exceeding 0.5% in Q2 2026, from its current -2.3% in Q1 2026. This would signal a clear rebound in the Public Affairs business and validate the impact of recent government contract wins. | A positive Citizens Segment Organic Growth validates the 'Political Spend '26' thesis and the 'Horizons' strategic plan, demonstrating the Public Affairs business's successful rebound and contribution to overall revenue acceleration. This would boost investor confidence in Ipsos's ability to meet full-year guidance and enhance its competitive position, driving a positive rerating. | 8% y/y growth | Yes | The Citizens segment (Public Affairs) posted strong organic growth of close to 8% in Q2 2026, significantly exceeding the rerating trigger of 0.5%. This performance confirms the countercyclical nature of the business and renewed interest from public and private decision-makers. | |
| Organic Growth | -1.4% | This is the primary top-line growth indicator for Ipsos. Management's confidence in achieving full-year guidance (2-3%) despite a negative Q1 hinges on an acceleration throughout the year, driven by strategic execution. Investors will closely watch for signs of this acceleration. | Organic growth of 0.5% to 1.5% in Q2 2026. This would demonstrate a clear acceleration from Q1's -1.4% and align with management's expectation of gradual acceleration towards the 2-3% full-year guidance. It should be supported by positive organic growth in the Citizens (Public Affairs) segment and organic order book growth exceeding 1%. | Hitting this threshold signals the 'Horizons' plan and Public Affairs rebound are gaining traction, validating management's full-year guidance. It demonstrates a clear path to revenue acceleration and core profitability improvements, boosting investor confidence in Ipsos's competitive position and future valuation. | ||||
| Order Book Organic Growth | 1% | Management explicitly uses order intake as a key KPI to predict future revenue, especially given the lag between orders and revenue recognition. A positive and accelerating order book growth signals future revenue expansion and validates the effectiveness of the 'Horizons' strategy. | For Ipsos S.A. (IPS.PA) to rerate higher, the Order Book Organic Growth metric needs to exceed 1% for Q2 2026, demonstrating a clear acceleration from the 1% organic growth reported in Q1 2026. This acceleration in order intake is crucial for validating the company's ability to achieve its full-year 2026 organic growth guidance of 2% to 3%. | Accelerating order book growth beyond 1% signals future revenue expansion and validates the 'Horizons' strategy, particularly the rebound in Public Affairs and AI/digital platform adoption. This would boost investor confidence in Ipsos's ability to meet full-year guidance, improving its competitive position and valuation. | 1.2% y/y growth | Yes | The order book was up 1.2% at the end of June 2026, which accounts for 75% of the company's annual revenue. This exceeded the rerating trigger of 1% and demonstrated acceleration from the prior quarter. | |
Key QuestionsWill Ipsos sustain the Q2 organic revenue growth momentum, particularly in Public Affairs and China, to achieve its full-year organic growth target of above 2%
Will Ipsos sustain the Q2 organic revenue growth momentum, particularly in Public Affairs and China, to achieve its full-year organic growth target of above 2% for 2026?
- Question 2
Can Ipsos effectively manage the continued dilutive impact from the BVA acquisition and the business mix shift towards lower-margin Public Affairs projects, alongside ongoing AI investments, to achieve its full-year operating profit margin target similar to 2025 levels, particularly given the H1 decline?
- Question 3
Will the 'wait-and-see' attitude from clients, attributed to the protracted Middle East conflict and broader macroeconomic uncertainty, intensify and materially impact Ipsos's H2 revenue and order intake beyond current expectations?
Earnings Transcript Summary
· 2026H1 Earnings Call
| 3 Things Management Is Most Focused On | Call Takeaway & Tone | Prior Quarter'S Y/Y Growth By Segment | 3 Things Analysts Most Pressed On (And Mgmt Responses) | Revenue Segments |
|---|---|---|---|---|
| 1. **Scaling up and global rollout of the Horizons program:** Management is focused on implementing and scaling up initiatives from the Horizons strategic program, particularly those leveraging artificial intelligence (AI) and digital services, to improve productivity, reduce survey lead times to under 48 hours, and enhance service offerings globally. 2. **Driving growth in key segments and geographies:** A key focus is on accelerating growth in specific areas, including the countercyclical Public Affairs business, CPG clients, the rebounding China market (especially in tech and automotive), pharmaceutical companies (driven by oncology and GLP-1 innovations), and sustained growth in the U.K. 3. **Maintaining strong financial health and shareholder returns:** Management is committed to cost control, evidenced by adapting its cost structure and achieving savings in general expenses. They are also focused on executing the share buyback program for cancellation (EUR 100 million for FY '26) and distributing a growing dividend (EUR 2 per share, up 8%). | The call conveyed a cautiously optimistic tone, highlighting a significant return to organic growth in Q2 2026 (3%) and H1 2026 (0.8%), a notable improvement from Q1's decline. Management expressed confidence in achieving full-year organic growth above 2%, driven by the successful implementation and scaling of the 'Horizons' strategic program, particularly through AI-powered solutions and globally managed services. Key themes included the countercyclical strength of Public Affairs, a strong rebound in China, and sustained growth in the pharmaceutical sector. While acknowledging external uncertainties like the protracted Middle East conflict and a recent 'wait-and-see' attitude from some clients, the overall message was positive regarding the company's strategic execution, robust financial health, and future growth prospects. | In Q1 2026, Ipsos reported an overall organic growth decline of 1.4%. Segment-wise, EMEA delivered 0.1% organic growth, Americas declined by 4.1% organically, and Asia Pacific was up 0.2% organically. By Audience segment, Consumer posted a positive organic growth of 0.5%, Clients and Employees Audience was down 3.3%, Citizens segment declined by 2.3% organically, and Doctors and Patients Audience was down 4.4% organically. The Ipsos.Digital platform recorded double-digit growth in Q1 2026. | 1. **Order book growth and potential acquisitions:** Analysts inquired how the 1.2% order book growth at the end of June translates to full-year revenue and asked about potential acquisitions. Management responded that the order book accounts for 75% of annual revenue and confirmed an active acquisition strategy targeting technological bricks (to build AI capabilities), neighboring markets (data analysis and integration), and expanding Ipsos's footprint in existing business lines. 2. **Depreciation of IT projects and AI investment CapEx/OpEx:** Analysts sought clarification on the EUR 11.6 million depreciation linked to halted IT projects and whether AI investments are treated as CapEx or OpEx. Management explained that the depreciation was primarily due to one major project not delivering expected results and two smaller tech assets being ceased. They clarified that CapEx was lower in H1 due to a one-off effect and redeployment, with a return to normal levels expected in H2, and that some AI costs (like token costs) are expensed as OpEx. 3. **H2 growth drivers beyond new initiatives, Americas (ex-Public Affairs), and China acceleration:** Analysts pressed for details on H2 growth drivers beyond new AI/GMS initiatives, the performance of the Americas business excluding Public Affairs, and the sustainability of China's acceleration given geopolitical developments. Management stated that growth is expected across all regions and audiences, enhanced by Horizons, with specific mention of the pharmaceutical industry. They emphasized looking at the Americas business as a whole, which picked up in Q2, and confirmed market share gains in China driven by new AI platforms despite macroeconomic developments. | Overall revenue for Q2 2026 stood at EUR 615 million, representing a total growth of 4.9% and organic growth of 3%. For the first half year (H1 2026), total revenue was EUR 1.170 billion, with 1.3% total growth and 0.8% organic growth. All three geographical areas (Americas, EMEA, Asia Pacific) returned to positive organic growth in Q2. EMEA posted 5.6% total revenue growth in H1, with Q2 organic growth of 0.9% (H1 organic growth of 0.5%). The Americas posted 0.7% organic growth in H1, with LatAm showing solid 6.3% growth and North America stable. Asia Pacific posted 2% organic growth for the first six months. By audience, Consumers, Clients and Employees showed close to 2% organic growth in Q2, Citizens posted strong organic growth close to 8% in Q2, and Doctors, Patients audience was sharply up with organic growth close to 3% in Q2. The Ipsos.Digital platform continued to record double-digit growth in Q2. |
· 2026Q1 Earnings Call
| 3 Things Management Is Most Focused On | Call Takeaway & Tone | Prior Quarter'S Y/Y Growth By Segment | 3 Things Analysts Most Pressed On (And Mgmt Responses) | Revenue Segments |
|---|---|---|---|---|
| 1. **Execution of the Horizons Strategic Plan**: Management is in full execution mode of their Horizons strategy, which includes leveraging their multi-specialist business offerings, deploying Globally Managed Services, expanding the Ipsos.Digital platform, and focusing on key markets like China and the U.S.. They expect this strategy to drive gradual revenue expansion throughout 2026. 2. **Rebound of Public Affairs Business**: After lackluster performance in previous years, management is highly focused on the return of Public Affairs, citing rising demand, increased order intake, and significant government contract wins in regions like the U.S., France, and the U.K. They believe it will be a key growth driver in 2026. 3. **Leveraging AI and Technology for Value Creation**: Ipsos is actively embedding AI technologies and digital platforms (Ipsos.Digital, Ipsos Synthesio) to create more value for clients, improve efficiency, and develop new solutions. Examples include using AI for behavioral measurement, social media analysis, and synthetic consumer digital twins. They have a roadmap for Q2, Q3, and Q4 launches of AI-powered products. | The overall takeaway of the call is one of cautious optimism. While Ipsos reported a negative organic growth in Q1 2026, management emphasized strong commercial momentum, a growing order book, and confidence in achieving their full-year organic growth guidance of 2% to 3%. The tone was mixed, acknowledging current challenges like currency headwinds and geopolitical impacts in the Middle East, but highlighting the strategic execution of the 'Horizons' plan, the rebound in Public Affairs, and significant investments in AI and digital platforms as key drivers for future growth. Management stressed that Q1's performance was anticipated and that growth would gradually accelerate throughout the year. | In Q4 2025, EMEA organic growth was 2.0%. Americas recorded 0.3% organic growth. Asia-Pacific experienced an organic decline of 2.5%. The Consumer segment showed 2.1% organic growth. The Clients and Employees segment also had 2.1% organic growth. The Citizens segment declined by 8.0% organically. The Doctors and Patients Audience segment grew by 2.4% organically. | 1. **Q1 organic growth decline and confidence in full-year guidance**: Analysts questioned the Q1 organic decline of 1.4% and management's confidence in achieving the full-year guidance of 2% to 3% organic growth. Management responded that the negative Q1 was in line with their expectations and that the growing order book (up 1% organically), similar historical order book percentages relative to full-year outlook, and granular country/service line analysis reinforce their confidence in meeting the guidance, expecting a gradual acceleration throughout the year. 2. **Impact of the Middle East conflict on revenue and profitability**: Analysts inquired about the impact of the Middle East conflict, especially given the 4.4% organic decline in the region (3% of total revenue). Management stated that the impact was a 'couple of million' and primarily limited to the MENA region, with no significant consequences observed outside of it. They also mentioned taking quick actions to mitigate profitability impact (e.g., hiring freeze) and are prepared to adjust the cost base if the conflict escalates or prolongs, but their current guidance does not assume such an escalation. 3. **Healthcare business decline, Clients and Employees activity decline, and expected Q2 organic growth**: Analysts asked about the Q1 decline in the Healthcare business (Doctors and Patients) and Clients and Employees activity, and whether Q2 would still be negative. Management explained that the Healthcare decline was due to tough comparisons from a strong Q1 2025 and a slowdown in qualitative studies, but order intake is improving. For Clients and Employees, the decline was attributed to timing effects in Audience Measurement, with a positive order book indicating future improvement. They reiterated that while they don't guide by quarter, they expect a gradual acceleration of growth throughout the year, implying an improvement from Q1, but not necessarily positive in Q2. | In Q1 2026, Ipsos reported an overall organic growth decline of 1.4%. Segment-wise, EMEA delivered 0.1% organic growth, Americas declined by 4.1% organically, and Asia Pacific was up 0.2% organically. By Audience segment, Consumer posted a positive organic growth of 0.5%, Clients and Employees Audience was down 3.3%, Citizens segment declined by 2.3% organically, and Doctors and Patients Audience was down 4.4% organically. The Middle East, representing about 3% of total revenue, saw an organic decline of 4.4%. |
Transcript Tidbits
| About Expanding Eligible Market | About Competition | About The Broader Industry | Where Things Are Headed | Updates On Theme | Broader Themes Emerging | Bullish-Leaning Quotes (Short) | Bearish-Leaning Quotes (Short) | Hiring |
|---|---|---|---|---|---|---|---|---|
| Ipsos is experiencing rising demand in Public Affairs, which shows a countercyclical aspect, and significant traction with CPG clients. There's a rebound in China driven by local tech and automotive clients, and international consumer goods clients. Business acceleration is noted in pharmaceutical companies for syndicated and ad hoc surveys, particularly in oncology and GLP-1. The company is seeing sustained growth in the U.K. and solid organic growth in LatAm (6.3% in H1). All three geographical areas (Americas, EMEA, Asia Pacific) and four main audiences are growing, a first since at least 2023. Ipsos.Digital platform continues to record double-digit growth. The company is pursuing an acquisition strategy for 'technological bricks' and to expand into 'neighboring markets' like data analysis and integration of multiple sources, as well as broadening its footprint by acquiring similar companies in existing markets. | Ipsos highlights its organic growth as a main differentiating factor compared to others. The company emphasizes its unique ability to conduct large-scale, complex surveys with robust face-to-face and telephone collection, which is a competitive advantage. Ipsos positions its platform to meet speed and differentiation requirements. In China, Ipsos has secured market share gains and is the leading player in the industry. While acknowledging pressure on prices in highly competitive markets, Ipsos notes that its ability to provide faster and cheaper services (unit prices) is compensated by higher volumes. The company also stresses the complementarity of its expertise, especially through proprietary panels and direct access to respondents, with major AI technological players who lack direct access to these respondents, helping to avoid issues like fraud and ensuring quality responses. | The broader industry is affected by a 'protracted conflict in the Middle East and the uncertainty as to its outcome,' leading to a 'wait-and-see attitude on the part of our customers' and some program postponements. The IMF has revised its growth outlook downward from 3.3% to 3%. The market is characterized by 'highly competitive markets' with 'pressure on prices.' There is a significant trend towards 'technological innovation, artificial intelligence' which is enabling companies like Ipsos to support strong growth and understand cutting-edge developments globally. | Ipsos expects a stronger business in H2 than in H1, driven by the scaling up of Horizons program initiatives, global rollout of managed services, and enriched digital service functions promoted commercially to support double-digit growth. New AI-powered tools will improve staff productivity, and specific initiatives are planned for China and the U.S. The company anticipates an improved order book for H2 and increased engagement with large accounts. For the full year, Ipsos expects organic growth above 2% and an operating margin similar to 2025. The company plans to cancel all bought-back shares by year-end and expects CapEx levels to return to last year's levels in H2. | Ad | Artificial Intelligence (AI) is a significant emerging theme, being integrated across various operations including data processing, augmenting production teams, social media monitoring (Synthesio), moderation of discussion groups, advertising assessment, and the Product Studio platform. The company is also focused on digital transformation to achieve faster survey completion times (under 48 hours) and enhancing data analysis and integration of multiple sources. In the pharmaceutical sector, innovation in oncology and GLP-1 obesity treatments is a key driver. | We are returning to growth. We are growing on all 4 fronts. Our order book is up 1.2%. Public Affairs, we are having a rising demand. Rebound in China as well in terms of orders. Sustained growth in Q2 [in the U.K.]. All regions in Q2 returned to positive organic growth. LatAm is solid, 6.3%. Asia Pacific... posting 2% organic growth. All audiences delivered positive growth in Q2. Citizens is posting strong organic growth, close to 8% in Q2. Doctors, patients audience sharply up too with organic growth close to 3% in Q2. Ipsos.Digital platform continues to record double-digit growth. Ipsos has a particularly strong balance sheet. Our leverage remains very low at 0.5x EBITDA. We generated free cash flow FCF of EUR 44.4 million, up EUR 4.6 million. We distributed a dividend of EUR 2 per share, up 8% over last year. We've achieved half this plan for EUR 50 million. We now expect a stronger business in H2 than in H1. We were able to secure gains in market shares in China. | Revenue for Q2 stands at EUR 615 million... compared with minus 2.4% in Q1 of last year. Organic growth in 3% to be compared with minus 1.4% in Q1. Revenue stands at EUR 1.170 billion... including 0.8% of organic growth. Organic growth on the EMEA region is penalized by a slowdown in the Middle East. The drop in our gross margin of 70 basis points in Q1 is due to 2 things: dilutive effect of the integration of BVA Family... but also effects linked to our business mix. Operating margin comes in at 7.9% down 40 basis points over H1 last year. Other nonrecurring costs, a negative balance of EUR 19 million, EUR 11 million of which depreciation linked to IT development projects that we've halted. Protracted conflict in the Middle East and the uncertainty as to its outcome. We have seen here and there a wait-and-see attitude on the part of our customers. Downward revision of growth outlook by the IMF from 3.3% to 3%. On highly competitive markets. There is pressure on prices. We're not expecting to continue to book a similar level [of restructuring costs] in H2. | Personnel costs are up 1.2% in the half due to acquisitions, but this increase is slightly lower than revenue growth as Ipsos continues to adapt its cost structure, with effects down 1% since the start of the year. The company incurred EUR 10.9 million in severance costs and EUR 6 million in reorganization costs following acquisitions and managerial changes. Alexandre Guerin has been appointed to lead an acceleration program focused on transforming tools for employees to reduce survey lead times, implying internal re-skilling and process optimization rather than external hiring or broad headcount reductions. |
| About Expanding Eligible Market | About Competition | About The Broader Industry | Where Things Are Headed | Updates On Theme | Broader Themes Emerging | Bullish-Leaning Quotes (Short) | Bearish-Leaning Quotes (Short) | Hiring |
|---|---|---|---|---|---|---|---|---|
| Ipsos is seeing rising demand and order intake in its Public Affairs business, which had previously underperformed, particularly in the U.S., France, and the U.K. The company has won prominent government contracts across multiple geographies. There is solid traction with consumer and packaged goods clients, which represent about a quarter of the business. Growth is being driven by North America, France, the U.K., and particularly robust performance in China. Ipsos is also expanding its footprint with its top 30 clients, which are significantly driving sales growth. The Ipsos.Digital platform recorded double-digit growth in Q1 2026. | Ipsos highlights its global footprint, present in 66 markets, as a differentiating asset, especially for serving public decision-makers and political polling. The company also emphasizes its proprietary panels and the ability to conduct face-to-face interviews in many large markets as competitive advantages. A key strategic choice is 'access to real people as a critically relevant competitive advantage,' with an increasing level of in-sourcing using their own panels rather than third-party providers. | The consumer and packaged goods sector is characterized by a 'volatile and rapidly changing environment,' driving sustained demand for deeper consumer behavior understanding. The macroeconomic environment is described as 'pretty volatile,' with potential for 'further inflation' and impact on the 'global economy' if the Middle East conflict continues or escalates. | Ipsos expects a gradual expansion of revenues throughout the remainder of 2026, driven by accelerating order intake and the full execution of its 'Horizons' strategy. The company maintains its full-year outlook of 2% to 3% estimated organic growth and an operating profit equivalent to 2025's 12.3%. Achieving equivalent profitability in 2026, despite the disposal of the profitable Russian business and the full-year impact of the dilutive BVA acquisition, implies an increase in core profitability. The company anticipates a 'gradual recovery' and 'acceleration throughout the year' in growth. Ipsos is preparing contingency plans for potential deterioration or escalation of the Middle East conflict. | The | Artificial Intelligence (AI) is a significant emerging theme, described as a 'catalyst for market leadership.' Ipsos is deploying AI solutions in the market, particularly resonating with consumer and packaged goods clients. The company is launching AI-powered products throughout 2026, including behavioral measurement using AI to analyze videos for subtle consumer signals, AI technologies to examine successful social media videos and identify influencers, and 'synthetic consumer digital twins' to replicate personality traits and behavioral logic for faster insights. | One notable encouraging signal is the fact that our Public Affairs business... is back, rising demand, rising order intake. We have a very robust performance in China. Our top 30 clients... drive our growth very significantly from a sales standpoint in Q1. I have confidence that Public Affairs will be one of the drivers of our growth in 2026. Our order intake at the end of Q1 actually is slightly better than what we thought. The short answer is it is doable. | Our revenue, which stands at EUR 555 million... is 2.4% less. Organic growth is minus 1.4%. There was a negative impact of currency of 540 basis points due to the appreciation of the euro against several currencies. Middle East... posted an organic decline of its revenue of 4.4% in the first quarter 2026. In the Americas... revenue declined by 4.1% on an organic basis. Doctors and Patients Audience revenue was down 4.4% on an organic basis. We are seeing obviously an erosion of our revenues to the tune of several millions. The situation, as we all know, remains highly volatile. | Ipsos mentioned a 'hiring freeze' as one of the actions they can take to mitigate the impact on profitability in the Middle East region if the conflict continues. The company also announced new leadership appointments, including Nathan Brumby as Chief Technology and Platforms Officer and Alexandre Boissy as Deputy CEO. Olivier Champourlier's role as Chief Financial Officer was confirmed. The entire workforce of '20,000 or close there to people at Ipsos' and leaders globally are being mobilized for strategy execution. |
Notes
| Date | Comment | Comment Type | Comment Sentiment | Link | Price Reaction |
|---|---|---|---|---|---|
| 2026-07-22 | Ipsos reported a strong Q2 rebound with 3% organic growth, leading to positive H1 organic growth of 0.8%, exceeding Q1's decline. All regions and audiences grew, driven by Public Affairs, China, and pharma. The company reiterated its full-year organic growth outlook above 2% and highlighted accelerating AI and digital initiatives. The market reacted very positively, with the stock gaining 7.82% (outperforming SPY), reflecting confidence in the return to growth and strategic execution. | Earnings Transcript | Positive | +7.82% (vs SPY: +8.95%) |
Upcoming Events
| Catalyst ID | Estimated Timing | Estimated Date Start | Estimated Date End | Catalyst | Why It Matters | Ticker Or Theme Specific | Transcript Date | Source Type |
|---|---|---|---|---|---|---|---|---|
| IPS.PA_5f2b28c3 | remainder of 2026 | 2026-04-17 | 2026-12-31 | Ipsos achieving its full-year 2026 guidance of 2% to 3% organic growth and an operating profit margin equivalent to 2025 (12.3%). | Meeting or exceeding this guidance would positively impact investor sentiment and valuation, while falling short could have a negative impact on the stock. | Ticker | 2026-04-16 | earnings_transcript |
| IPS.PA_9c349b81 | one of the drivers of our growth in 2026, Throughout 2026, culminating in November elections | 2026-04-17 | 2026-11-30 | The Public Affairs business segment demonstrating strong growth in 2026, driven by increased demand and prominent government contracts, aligning with the projected record spending for the 2026 U.S. midterm elections. | A strong rebound in Public Affairs, supported by a significant political super cycle, would positively impact Ipsos's overall revenue growth and investor sentiment. | Ticker | 2026-04-16 | earnings_transcript |
| IPS.PA_474e6262 | bear fruits increasingly as quarters after quarter things happen, throughout the year | 2026-04-17 | 2026-12-31 | Materialization of benefits from the Horizons strategic plan, including the expansion of Globally Managed Services, growth of Ipsos.Digital, and successful commercial acceleration. | The Horizons strategy is expected to drive revenue expansion and strengthen growth; successful execution would positively impact financial results and investor confidence. | Ticker | 2026-04-16 | earnings_transcript |
| IPS.PA_f617d078 | Q2, Q3 and Q4 launches of AI-powered products | 2026-04-01 | 2026-12-31 | Ipsos successfully launching and achieving market adoption for its new AI-powered products and solutions throughout Q2, Q3, and Q4 2026. | Successful new product launches, particularly in AI, can enhance Ipsos's competitive position, drive demand, and contribute to revenue growth. | Ticker | 2026-04-16 | earnings_transcript |
| IPS.PA_fc7a6764 | Ongoing throughout 2026, with key dates in June and August | 2026-06-09 | 2026-12-31 | Evolving advertising regulations, particularly concerning AI-generated content and data privacy (e.g., New York's 'synthetic performers' law, EU AI Act), taking effect and impacting Ipsos's AI strategies and compliance processes. | These regulations create both challenges and opportunities for Ipsos, requiring adaptation of AI strategies and implementation of new compliance processes, which could affect operational costs and market offerings. | Theme | 2026-04-16 | earnings_transcript |
| IPS.PA_9fd3f559 | remainder of the year, long run | 2026-04-17 | 2026-12-31 | The geopolitical situation in the Middle East either stabilizing or escalating, potentially impacting Ipsos's business outside the region and the global economy. | Escalation or prolonged conflict could lead to further revenue erosion, impact global economic conditions, and force Ipsos to adjust its cost base, negatively impacting profitability. | Theme | 2026-04-16 | earnings_transcript |
| IPS.PA_4c468777 | in the coming months | 2026-04-17 | 2026-07-31 | The Doctors and Patients Audience segment returning to positive organic growth after a Q1 decline, driven by improving order intake. | A rebound in this segment would contribute to overall organic growth and demonstrate improved demand from pharmaceutical industry clients. | Ticker | 2026-04-16 | earnings_transcript |
| IPS.PA_44d1630f | over the coming quarters | 2026-04-17 | 2026-09-30 | The Clients and Employees Audience Measurement activities translating positive order intake into positive growth over the coming quarters. | A return to positive growth in this segment, driven by order intake, would support overall revenue acceleration and contribute to meeting full-year guidance. | Ticker | 2026-04-16 | earnings_transcript |